Budoucí P/E společnosti Zynex
Jaká je hodnota metriky Budoucí P/E společnosti Zynex?
Hodnota metriky Budoucí P/E společnosti Zynex, Inc. je 27.17
Jaká je definice metriky Budoucí P/E?
Budoucí poměr P/E (Forward price to earnings ratio) vyjadřuje poměr současné ceny a odhadovaného zisku na akcii v následujících dvanácti měsících.
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
Budoucí P/E společností v sektoru Health Care sektor na EURONEXT ve srovnání se společností Zynex
Čemu se věnuje společnost Zynex?
Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain; and activate and exercise muscles for rehabilitative purposes with electrical stimulation. The company offers NexWave, a dual channel, multi-modality interferential current, transcutaneous electrical nerve stimulation, and neuromuscular electrical stimulation (NMES) device that is marketed to physicians and therapists by field sales representatives; NeuroMove, an electromyography triggered electrical stimulation device; InWave, an electrical stimulation product for the treatment of female urinary incontinence; and E-Wave, an NMES device. It also supplies private labeled products, including electrodes for the delivery of electrical current to the body, and batteries for use in electrotherapy products. In addition, the company distributes Comfortrac/Saunders for cervical traction, JetStream for hot/cold therapy, LSO Back Braces for lumbar support, and knee braces for knee support. Further, it offers Zynex Fluid Monitoring System (CM-1500), a fluid volume monitor, which is a non-invasive medical device for monitoring relative fluid volume changes used in operating and recovery rooms to detect fluid loss during surgery and internal bleeding during recovery; Zynex Wireless Fluid Monitoring System (CM-1600), a noninvasive monitoring device designed to measure relative changes in fluid volume in adult patients; NiCO CO-Oximeter, a laser-based noninvasive co-oximeter; and HemeOx tHb Oximeter, a laser-based total hemoglobin pulse oximeter. The company provides its products for use in pain management and control; stroke and spinal cord injury rehabilitation; hemodynamic monitoring; and pulse oximetry monitoring. It sells its products through direct sales force primarily in the United States. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado.
Firmy s metrikou budoucí p/e podobnou společnosti Zynex
- Hodnota metriky Budoucí P/E společnosti Edenred SA je 27.03
- Hodnota metriky Budoucí P/E společnosti Carebook Technologies je 27.10
- Hodnota metriky Budoucí P/E společnosti Spirax-Sarco Engineering Plc je 27.10
- Hodnota metriky Budoucí P/E společnosti SoftBank je 27.10
- Hodnota metriky Budoucí P/E společnosti Gatos Silver Inc je 27.10
- Hodnota metriky Budoucí P/E společnosti Asia Cement (China) je 27.10
- Hodnota metriky Budoucí P/E společnosti Zynex je 27.17
- Hodnota metriky Budoucí P/E společnosti Prism Johnson je 27.25
- Hodnota metriky Budoucí P/E společnosti Trend Micro je 27.25
- Hodnota metriky Budoucí P/E společnosti First Solar Inc je 27.25
- Hodnota metriky Budoucí P/E společnosti Paychex je 27.26
- Hodnota metriky Budoucí P/E společnosti Alphabet Inc je 27.28
- Hodnota metriky Budoucí P/E společnosti Godrej Properties je 27.28